07-03-2012 10:25 PM CET - Health & Medicine
Print PDF Email

Insulin Market Forecast to 2015

Press release from: RNCOS E-Services Pvt. Ltd.
PR Agency: RNCOS E-Services Pvt. Ltd.
RNCOS has recently added a new Market Research Report titled, “Insulin Market Forecast to 2015” to its report gallery.
RNCOS has recently added a new Market Research Report titled, “Insulin Market Forecast to 2015” to its report gallery.
RNCOS has recently added a new Market Research Report titled, “Insulin Market Forecast to 2015” to its report gallery. In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global market for insulin products is progressing on the strong growth trajectory as the number of people suffering from diabetes is increasing at a rapid rate worldwide. It is estimated that the market will advance at a CAGR of around 10% during 2012-2015.

The report, “Insulin Market Forecast to 2015”, says that new innovations in delivery devices are also likely to fuel growth in the global insulin market. In the recent years, many alternatives to insulin syringes have been launched, including pen devices, and insulin pumps. Our comprehensive research work also studies how government initiatives are stimulating the growth, and what are the challenges that the overall market may face in near future.

Our extensive study looks into the competitive landscape and finds that Novo Nordisk is the top player in the global insulin market, followed by Sanofi-Aventis and Eli Lilly. The report includes an overview of the activities of these companies. It also studies key geographies, such as BRIC nations and the United States to understand the structure of the insulin market in these countries. Overall, the research aims at presenting a balanced picture of the global insulin market to clients.

For FREE SAMPLE of this report visit: www.rncos.com/Report/IM430.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015 (www.rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

None

B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

This release was published on openPR.
News-ID: 227633
del.icio.us:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine MisterWong:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine Digg:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine StumbleUpon:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine Technorati:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine Reddit:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine Furl:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine WebNews:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine OneView:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine LinkArena:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine YiGG:Insulin Market Forecast to 2015 - Pressreleases - openPR - Health & Medicine
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.